Nouvelle déclaration d'incident
No de la demande: 2019-4226
Numéro de référence du titulaire d'homologation: 2436630
Nom du titulaire (nom légal complet, aucune abbréviation): Bell Laboratories, Inc.
Adresse: 3699 Kinsman Blvd
Ville: Madison
État: WI
Pays: USA
Code postal /Zip: 53704
Incident chez un animal domestique
Pays: UNITED STATES
État: INDIANA
ARLA No d'homologation ARLA No de la demande d'homologation EPA No d'homologation. 12455-91
Nom du produit: Final Rodenticide RTU Place Pac
Appât
Inconnu
Inconnu
Inconnu
Propriétaire de l'animal
Dog / Chien
Toy Poodle
1
Femme
1.50
7.00
lbs
Inconnu
<=15 min / <=15 min
>3 days <=1 wk / >3 jours <=1 sem
Système
Persisted until death
Oui
Non
Inconnu
Mort
Other / Autre
préciser Speculated ingestion of pesticide
(p.ex. description des symptômes tels que la fréquence et la gravité
First call received 5/7/2019 7:57:54 AM. On April 29, 2919, a pet owner found an open pouch of Final Rodenticide RTU Place Pac on her dog's bed. She didn't know if the dog ingested any pellets or not and did not seek veterinary care. On May 6, 2019 the dog developed shortness of breath and was whining if picked up. On May 7, she refused to eat. At the advice of the Bell Labs medical line, she was advised to bring her dog immediately to her veterinarian for examination and possible treatment. Later that same day, her dog was examined by a veterinarian and treated with an injection of Vitamin K1 and also started on oral Vitamin K1 pills and a high fat diet to encourage Vitamin K absorption. No mention of diagnostic tests or physical exam findings were given by the pet owner. She was advised by the veterinarian to bring her dog back the following day for a blood transfusion. On May 9, 2019, the pet owner reported that her dog died at home later in the afternoon of May 7. She reported there is a second dog in her home which was asymptomatic. Veterinary evaluation and diagnostic testing were recommended for the second dog.
Mort
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.